Biomarin Pharmaceutical Inc (BMRN)
Solvency ratios
|
Sep 30, 2025 |
Jun 30, 2025 |
Mar 31, 2025 |
Dec 31, 2024 |
Sep 30, 2024 |
Jun 30, 2024 |
Mar 31, 2024 |
Dec 31, 2023 |
Sep 30, 2023 |
Jun 30, 2023 |
Mar 31, 2023 |
Dec 31, 2022 |
Sep 30, 2022 |
Jun 30, 2022 |
Mar 31, 2022 |
Dec 31, 2021 |
Sep 30, 2021 |
Jun 30, 2021 |
Mar 31, 2021 |
Dec 31, 2020 |
| Debt-to-assets ratio |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Debt-to-capital ratio |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Debt-to-equity ratio |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Financial leverage ratio |
1.26 |
1.24 |
1.23 |
1.24 |
1.27 |
1.34 |
1.35 |
1.38 |
1.38 |
1.37 |
1.38 |
1.38 |
1.37 |
1.36 |
1.38 |
1.41 |
1.40 |
1.39 |
1.39 |
1.42 |
Coverage ratios
|
Sep 30, 2025 |
Jun 30, 2025 |
Mar 31, 2025 |
Dec 31, 2024 |
Sep 30, 2024 |
Jun 30, 2024 |
Mar 31, 2024 |
Dec 31, 2023 |
Sep 30, 2023 |
Jun 30, 2023 |
Mar 31, 2023 |
Dec 31, 2022 |
Sep 30, 2022 |
Jun 30, 2022 |
Mar 31, 2022 |
Dec 31, 2021 |
Sep 30, 2021 |
Jun 30, 2021 |
Mar 31, 2021 |
Dec 31, 2020 |
| Interest coverage |
64.46 |
76.74 |
57.25 |
43.75 |
25.15 |
18.54 |
14.78 |
11.84 |
11.17 |
7.82 |
5.51 |
10.33 |
7.17 |
4.62 |
3.28 |
-3.95 |
-2.01 |
-1.91 |
-3.62 |
-0.46 |
